Dopamine Transporter Deficiency Syndrome (DTDS), also referred to as Infantile Parkinsonism-Dystonia, is an exceptionally rare genetic disorder affecting only about 50 children globally. This debilitating condition is caused by a recessive genetic mutation in the SLC6A3 gene, which is crucial for the proper functioning of dopamine transporters in the brain. These transporters are responsible for regulating dopamine levels, a neurotransmitter essential for motor control and a variety of other neurological functions. Children with DTDS often exhibit symptoms akin to Parkinson's disease, including severe motor dysfunction, muscle rigidity, and involuntary movements. Due to its rarity, research and treatment options for DTDS are limited, posing significant challenges for affected families and healthcare providers.